MétaCan
Menu
Back to cohort
Record W2171430909 · doi:10.1158/1055-9965.epi-12-0229

A Nonsynonymous Polymorphism in<i>IRS1</i>Modifies Risk of Developing Breast and Ovarian Cancers in<i>BRCA1</i>and Ovarian Cancer in<i>BRCA2</i>Mutation Carriers

2012· article· en· W2171430909 on OpenAlexfundno aff
Yuan Chun Ding, Lesley McGuffog, Sue Healey, Eitan Friedman, Yael Laitman, Shani- Paluch–Shimon, Bella Kaufman, Annelie Liljegren, Annika Lindblom, Håkan Olsson, Ulf Kristoffersson, Marie Stenmark‐Askmalm, Beatrice Melin, Susan M. Domchek, Katherine L. Nathanson, Timothy R. Rebbeck, Anna Jakubowska, Jan Lubiński, Katarzyna Jaworska, Katarzyna Durda, Jacek Gronwald, Tomasz Huzarski, Cezary Cybulski, Tomasz Byrski, Ana Osório, Teresa Ramóny Cajal, Alexandra Stavropoulou, Javier Benı́tez, Ute Hamann, Matti A. Rookus, Cora M. Aalfs, Judith L. de Lange, Hanne Meijers‐Heijboer, Jan C. Oosterwijk, Christi J. van Asperen, E. Gómez, Agnes Jager, Rob B. van der Luijt, Douglas F. Easton, Susan Peock, Debra Frost, Steve D. Ellis, Radka Platte, Elena Fineberg, D. Gareth Evans, Fiona Lalloo, Louise Izatt, Rosalind A. Eeles, Julian Adlard, Rosemarie Davidson, Diana Eccles, Trevor Cole, Jackie Cook, Carole Brewer, Marc Tischkowitz, Andrew K. Godwin, Harsh B. Pathak, Dominique Stoppa‐Lyonnet, Olga M. Sinilnikova, Sylvie Mazoyer, Laure Barjhoux, Mélanie Léoné, Marion Gauthier‐Villars, Virginie Caux‐Moncoutier, Antoine De Pauw, Agnès Hardouin, Pascaline Berthet, Hélène Dreyfus, Sandra Fert Ferrer, Marie‐Agnès Collonge‐Rame, Johanna Sokolowska, Saundra Buys, Mary B. Daly, Alex Miron, Mary Beth Terry, Wendy K. Chung, Esther M. John, Melissa C. Southey, David E. Goldgar, Christian F. Singer, Muy-Kheng M. Tea, Daphne Gschwantler‐Kaulich, A. Fink-Retter, Thomas van Overeem Hansen, Bent Ejlertsen, Oskar T. Johannsson, Kenneth Offit, Kara Sarrel, Mia M. Gaudet, Joseph Vijai, Mark E. Robson, Marion Piedmonte, Lesley Andrews, David E. Cohn, Leslie R. DeMars, Paul DiSilvestro, Gustavo C. Rodriguez, Amanda E. Toland, Marco Montagna, Simona Agata, Evgeny Imyanitov, Claudine Isaacs, Ramūnas Janavičius, Conxi Lázaro, Ignacio Blanco, Susan J. Ramus, Lara Sucheston, Beth Y. Karlan, Jenny Gross, Patricia A. Ganz, Mary Beattie, Rita K. Schmutzler, Barbara Wappenschmidt, Alfons Meindl, Norbert Arnold, Dieter Niederacher, Sabine Preisler-Adams, D Gadzicki, Raymonda Varon-Mateeva, Helmut Deißler, Andrea Gehrig, Christian Sutter, Karin Kast, Heli Nevanlinna, Kristiina Aittomäki, Jacques Simard, Amanda B. Spurdle, Jonathan Beesley, Gail E. Tomlinson, Jeffrey N. Weitzel, Judy E. Garber, Olufunmilayo I. Olopade, Wendy S. Rubinstein, Nadine Tung, Joanne L. Blum, Steven A. Narod, Sean S. Brummel, Daniel L. Gillen, Noralane M. Lindor, Zachary Fredericksen, V. Shane Pankratz, Fergus J. Couch, Paolo Radice, Paolo Peterlongo, Mark H. Greene, Jennifer T. Loud, Irene L. Andrulis, Gord Glendon, Hilmi Özçelik, Anne‐Marie Gerdes, Mads Thomassen, Uffe Birk Jensen, Anne‐Bine Skytte, Maria A. Caligo, Andrew Lee, Georgia Chenevix‐Trench, Antonis C. Antoniou, Susan L. Neuhausen

Bibliographic record

VenueCancer Epidemiology Biomarkers & Prevention · 2012
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsnot available
FundersNational Center for Advancing Translational SciencesBreast Cancer IrelandNational Institute of Environmental Health SciencesCanadian Institutes of Health ResearchNational Institute for Health and Care ResearchNational Cancer InstituteCancer Research UKNational Institutes of HealthNational Center for Research ResourcesCancer Research Institute
KeywordsNonsynonymous substitutionOvarian cancerBreast cancerOncologyCancerInternal medicineMedicineGynecologyBiologyGeneticsGene

Abstract

fetched live from OpenAlex

BACKGROUND: We previously reported significant associations between genetic variants in insulin receptor substrate 1 (IRS1) and breast cancer risk in women carrying BRCA1 mutations. The objectives of this study were to investigate whether the IRS1 variants modified ovarian cancer risk and were associated with breast cancer risk in a larger cohort of BRCA1 and BRCA2 mutation carriers. METHODS: IRS1 rs1801123, rs1330645, and rs1801278 were genotyped in samples from 36 centers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Data were analyzed by a retrospective cohort approach modeling the associations with breast and ovarian cancer risks simultaneously. Analyses were stratified by BRCA1 and BRCA2 status and mutation class in BRCA1 carriers. RESULTS: Rs1801278 (Gly972Arg) was associated with ovarian cancer risk for both BRCA1 (HR, 1.43; 95% confidence interval (CI), 1.06-1.92; P = 0.019) and BRCA2 mutation carriers (HR, 2.21; 95% CI, 1.39-3.52, P = 0.0008). For BRCA1 mutation carriers, the breast cancer risk was higher in carriers with class II mutations than class I mutations (class II HR, 1.86; 95% CI, 1.28-2.70; class I HR, 0.86; 95%CI, 0.69-1.09; P(difference), 0.0006). Rs13306465 was associated with ovarian cancer risk in BRCA1 class II mutation carriers (HR, 2.42; P = 0.03). CONCLUSION: The IRS1 Gly972Arg single-nucleotide polymorphism, which affects insulin-like growth factor and insulin signaling, modifies ovarian cancer risk in BRCA1 and BRCA2 mutation carriers and breast cancer risk in BRCA1 class II mutation carriers. IMPACT: These findings may prove useful for risk prediction for breast and ovarian cancers in BRCA1 and BRCA2 mutation carriers.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.317
Teacher spread0.295 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations23
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueCancer Epidemiology Biomarkers & PreventionSame topicBRCA gene mutations in cancerFrench-language works237,207